Although developing new diagnostic techniques is cheap compared with developing new drugs (largely because they do not have to undergo such comprehensive and expensive clinical trials), it is frequently not cheap enough to create tests that will be commercially viable if their only market is in the poor world.
ECONOMIST: A poor diagnosis